HMA consultants have been referring to these payments as “HHS 1” and “HHS 2”. Both payments required physicians to attest and accept the terms and conditions of the payments or it was assumed by HHS that the group accepted the payments by default. Since mid-April, HHS has issued very little guidance on how these funds can be

HMA: Joint Letter by the European Commission, EMA and HMA June 2019 LETTER TO STAKEHOLDERS REGARDING THE REQUIREMENTS TO PROVIDE RESULTS FOR 1 Guidance on posting and publication of result-related information on clinical trials in relation to the implementation of Article 57(2) of Webinar conference organised on 15 May about the Guidance Webinar conference: Guidance on the management of clinical trials during the COVID-19 pandemic Friday 15 May at 15.00 CET, Brussels time DG SANTE will host a webinar conference jointly with EMA and the Clinical Trials Coordination and Facilitation Group of HMA following this … Guidance Issued on Spending the Cares Act Relief Fund HMA consultants have been referring to these payments as “HHS 1” and “HHS 2”. Both payments required physicians to attest and accept the terms and conditions of the payments or it was assumed by HHS that the group accepted the payments by default. Since mid-April, HHS has issued very little guidance on how these funds can be Latest Guidance of the EMA and European and UK National

The guidance was agreed by the Clinical Trials Expert Group (CTEG) of the European Commission, supported by EMA, the Clinical Trials Facilitation and Coordination Group (CTFG) of HMA and the GCP Inspectors’ Working Group. It provides a harmonised approach in the conduct of trials, in order to mitigate the negative effects of the pandemic.

The Heads of Medicines Agencies (HMA) is a network of the heads of the 'national competent authorities', the agencies responsible for the regulation of human and veterinary medicines in the individual countries of the European Economic Area (EEA).. The HMA works to foster an effective and efficient European medicines regulatory system.It is supported by working groups covering specific … Hazard Mitigation Overview

HMA GUIDANCE – JANUARY 2019 6 government who is the primary point of contact with FEMA, other Federal agencies, and local governments in mitigation planning and implementation of mitigation programs and activities

Availability of medicines | European Medicines Agency The guidance contains a reporting template for use if none is provided by the country in question. EMA and HMA intend to begin implementing the guidance in a pilot phase starting in Q1 2020, and will provide further information for marketing authorisation holders in advance. Hazard Mitigation Assistance - Louisiana The eligible activities for funding under the Hazard Mitigation Assistance (HMA) Programs fall into the following categories: For Information on Hazard Mitigation Project Funding in your area contact the local OEP office (Office of Emergency Preparedness) in the Parish in which you live.